Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2022

Bristol Myers Squibb - The role of immuno-oncology in GI cancers: Best practice and clinical questions

Advances in immuno-oncology for esophageal cancer: First-line metastatic disease and earlier stages

Date

04 Dec 2022

Session

Bristol Myers Squibb - The role of immuno-oncology in GI cancers: Best practice and clinical questions

Topics

Tumour Site

Gastro-Oesophageal Junction Cancer

Presenters

Chih-Hung Hsu

Authors

C. Hsu

Author affiliations

  • Oncology Department, National Taiwan University Hospital, 10002 - Taipei City/TW

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction

Presenter: Matthew Chau Hsien Ng

Session: Bristol Myers Squibb - The role of immuno-oncology in GI cancers: Best practice and clinical questions

Resources:

Webcast

Q&A and summary

Presenter: Matthew Chau Hsien Ng

Session: Bristol Myers Squibb - The role of immuno-oncology in GI cancers: Best practice and clinical questions

Resources:

Webcast

Close

Presenter: Matthew Chau Hsien Ng

Session: Bristol Myers Squibb - The role of immuno-oncology in GI cancers: Best practice and clinical questions

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.